[ALNY] QoQ Quarter Result on 30-Jun-2018 [#Q2]

Stock
[ALNY] Alnylam Pharmaceuticals, Inc.
Announcement Date
02-Aug-2018
Financial Year
2018
Quarter
30-Jun-2018 [#Q2]
Profit Trend
QoQ- -15.82%
YoY- -38.12%
Quarter Report
ALNY's Result
ALNY's Financial Summary
View:
Show?
Quarter Result
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
Revenue 33,294 21,033 2,069 29,907 21,899 37,924 17,096 56.01%
PBT -181,220 -211,080 -244,837 -163,481 -141,276 -142,227 -122,937 29.55%
Tax 695 361 445 79 -62 -7,949 -3,296 -
NP -181,915 -211,441 -245,282 -163,560 -141,214 -142,227 -122,937 29.88%
Tax Rate - - - - - - - -
Total Cost 215,209 232,474 247,351 193,467 163,113 180,151 140,033 33.20%
Ratio Analysis
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
NP Margin -546.39 -1,005.28 -11,855.10 -546.90 -644.84 -375.03 -719.10 -16.74%
Per Share
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
EPS -1.73 -2.09 -2.43 -1.63 -1.41 -1.48 -1.34 18.58%
EPS Diluted -1.73 -2.09 -2.43 -1.63 -1.41 -1.48 -1.34 18.58%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.